Procter & Gamble Health total sale up by 3 percent at Rs 238 crores for December quarter
Advertisement
Mumbai: Procter & Gamble Health Limited (formerly Merck Limited) has recently announced its financial results for the half year ended December 31, 2020. The company has recorded a total sale of Rs. 238 crores for the quarter ended December 31, 2020, up 3% vs year ago. The Profit After Tax (PAT) was Rs. 68 crores vs Rs. 38 crores year ago, driven primarily by lower travel and selling expenses due to Covid-19 pandemic. Sales for the six-month period ending December 31, 2020 were Rs. 496 crores, up by 10% vs year ago. Profit After Tax for same period was Rs. 127 Crore.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.